![Bai Teng Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 M $ in data 31/07/2026
Bai Teng Zhao was the founder of ProfoundBio (Suzhou) Co., Ltd., established in 2018, and held the titles of Chairman & General Manager from 2018 to 2024.
Currently, Dr. Zhao is a Director at Piton Therapeutics Inc and an Independent Director at Whitehawk Therapeutics, Inc. since 2024.
Dr. Zhao completed undergraduate studies at Peking University and earned a doctorate from The University of Texas at Austin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 1.250.000 ( 2,65% ) | 5 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/12/2024 |
Precidiag, Inc.
 Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
ProfoundBio (Suzhou) Co., Ltd.
 ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Amministratore Delegato | 01/05/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProfoundBio (Suzhou) Co., Ltd.
ProfoundBio (Suzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development of novel targeted therapeutics | Commercial Services |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Precidiag, Inc.
Precidiag, Inc. Packaged SoftwareTechnology Services Operates as an AI-enabled precision medicine biotech company providing precision therapeutics for chronic and systemic diseases | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
